Michael Benatar Selected Research

Biomarkers (Surrogate Marker)

12/2023	Biomarker Qualification for Neurofilament Light Chain in ALS: Theory and Practice.
1/2023	Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal.
1/2023	The best and worst of times in therapy development for myasthenia gravis.
1/2023	Presymptomatic amyotrophic lateral sclerosis: from characterization to prevention.
1/2023	Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study.
1/2022	Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosis.
1/2022	Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
1/2022	Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study.
8/2021	Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design.
1/2021	Humoral response to neurofilaments and dipeptide repeats in ALS progression.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Benatar Research Topics

Disease

34	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2023 - 04/2007
27	Myasthenia Gravis 01/2024 - 07/2006
8	Disease Progression 01/2023 - 05/2011
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2013
3	Infections 12/2023 - 05/2010
3	Frontotemporal Dementia (Semantic Dementia) 01/2022 - 01/2012
3	Asymptomatic Diseases 01/2022 - 01/2018
2	Neoplasms (Cancer) 12/2023 - 01/2023
2	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 04/2015
2	Spinal Cord Diseases 01/2023 - 02/2007
2	Stroke (Strokes) 01/2023 - 02/2009
2	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2022 - 02/2015
2	Headache (Headaches) 01/2021 - 12/2017
2	Thymoma (Thymic Carcinoma) 11/2020 - 12/2017
2	Proteostasis Deficiencies 05/2013 - 03/2013
2	Ischemic Stroke 02/2009 - 01/2008
1	Prodromal Symptoms 01/2023
1	Spastic Ataxia 01/2023
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2023
1	Rare Diseases (Rare Disease) 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Inflammation (Inflammations) 08/2021
1	Meningococcal Infections 01/2019
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2019
1	Fatigue 01/2018
1	Thymus Neoplasms (Thymus Neoplasm) 12/2017
1	Meningococcal Meningitis 12/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2017
1	Respiratory Insufficiency (Respiratory Failure) 12/2016
1	Guillain-Barre Syndrome 12/2016
1	Autonomic Nervous System Diseases (Dysautonomia) 12/2016
1	Vascular Diseases (Vascular Disease) 07/2015

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 12/2023 - 11/2010
12	Cholinergic ReceptorsIBA 12/2023 - 07/2006
8	Proteins (Proteins, Gene)FDA Link 08/2023 - 01/2012
5	AntibodiesIBA 12/2023 - 07/2006
4	glucose-mannose-glucoseIBA 01/2024 - 01/2019
4	Rituximab (Mabthera)FDA Link 12/2021 - 09/2017
4	Prednisone (Sone)FDA LinkGeneric 11/2020 - 03/2016
3	Monoclonal AntibodiesIBA 01/2024 - 01/2021
3	neonatal Fc receptorIBA 12/2023 - 01/2021
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2020 - 01/2018
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019 - 06/2007
3	Edrophonium (Tensilon)FDA LinkGeneric 01/2019 - 07/2006
3	Intravenous Immunoglobulins (IVIG)FDA Link 12/2017 - 10/2013
3	SteroidsIBA 07/2016 - 10/2008
3	Valosin Containing ProteinIBA 09/2012 - 12/2010
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	AutoantibodiesIBA 01/2023 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2015
2	Complement System Proteins (Complement)IBA 01/2023 - 12/2017
2	Superoxide Dismutase-1IBA 01/2022 - 03/2013
2	tofersenIBA 01/2022 - 01/2022
2	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2022 - 03/2017
2	Antisense OligonucleotidesIBA 01/2022 - 01/2019
2	margatoxinIBA 11/2020 - 01/2019
2	Complement Inactivating AgentsIBA 01/2020 - 12/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 12/2012
2	Phosphotransferases (Kinase)IBA 01/2019 - 09/2017
2	eculizumab FDA Link 01/2019 - 12/2017
2	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 03/2016 - 02/2008
2	Amino Acids FDA Link 03/2013 - 12/2010
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 02/2010 - 02/2008
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023
1	N 30IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Nitrous Oxide (Laughing Gas)IBA 01/2023
1	B-Cell Maturation AntigenIBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	NeopterinIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	EdaravoneIBA 08/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	DipeptidesIBA 01/2021
1	rozanolixizumabIBA 01/2021
1	ChitinasesIBA 01/2020
1	zilucoplanIBA 01/2020
1	rho-Associated KinasesIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	fasudil (AT 877)IBA 01/2019
1	polyetheretherketoneIBA 01/2018
1	arimoclomolIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 09/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2017
1	Methotrexate (Mexate)FDA LinkGeneric 07/2016
1	Retinaldehyde (Retinal)IBA 07/2015
1	Immunomodulating AgentsIBA 04/2015

Therapy/Procedure

24	Therapeutics 01/2024 - 04/2007
6	Thymectomy 11/2020 - 10/2013
5	Activities of Daily Living (ADL) 01/2024 - 07/2016
2	Plasma Exchange 12/2017 - 10/2013
1	Traditional Medicine (Folk Remedies) 12/2023
1	Injections 12/2023
1	Plasmapheresis 12/2016
1	Physical Therapy Modalities (Physical Therapy Technique) 12/2016
1	Artificial Respiration (Mechanical Ventilation) 12/2016
1	Immunotherapy 12/2016
1	Noninvasive Ventilation 12/2016
1	Denervation 02/2015